Brian Diethorn

Brian Diethorn is an experienced professional in the preclinical medical device industry, currently serving as the Executive Director of Preclinical Medical Devices at Labcorp Drug Development since October 2018.1 He is based in Miami, Florida, United States.1

With over 15 years of experience in the field, Diethorn has a strong background in preclinical research and medical device development.1 His current role involves managing all preclinical medical device operations and optimizing a portfolio with clients ranging from startups to Fortune 500 companies.1

Career Highlights

• Labcorp Drug Development: As Executive Director, Diethorn serves as a trusted advisor to C-Suite leaders, Study Directors, and internal stakeholders. He manages contracts, negotiates pricing with vendors globally, and ensures excellence in customer experience and compliance.1

• PMI - Preclinical Medevice Innovations: Prior to his current role, Diethorn held several positions at PMI, including:

  • Chief Operating Officer (2014-2018)
  • Senior Director Business Development (2011-2014)
  • Sr Project Manager (2008-2011)1

• Previous Experience: Diethorn has also worked at Harvard Medical School, PDL BioPharma, Smith-Kettlewell, Charles River Laboratories, University of Washington, and University of Pittsburgh in various research and management roles.1

Education

Diethorn's educational background includes studies in Biology at the Community College of Allegheny County and the University of Pittsburgh, as well as attendance at Southern New Hampshire University.1

Achievements

During his tenure as COO at PMI, Diethorn led significant company initiatives, including rebranding efforts in 2015 and the successful acquisition and merger of SSV, LLC in 2016.1 Under his leadership, PMI was awarded Best Pre-Clinical CRO - California by Global Health & Pharma in 2016.2